NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Sentiment,

Q1

Can Linda Powers confirm that the Autolomous employees (https://www.autolomous.com/) have been working with Northwest Biotherapeutics on developing & deploying their AutoloMATE eBMR solution (Phase 1) and that the Autolomous team are NOW busy working remotely, building Proof-of-concepts with Northwest Biotherapeutics and developing the next stages (Phase 2 and Phase 3) of their AutoloMATE platform?

Q2

At the beginning of the year, important information about the future of Northwest Biotherapeutics in the UK was available on the following website: https://www.mill-lane-sawston.co.uk/.

Was Northwest Biotherapeutics one of the initiators for the construction of this website and why is the information currently not available?
(Note: IMO only a minority of the NWBO ihub followers saved the information on their hard drive.)

Q3 (Less important)

On March 16 there is a new ‘Handelsregister–Bekanntmachung‘ ( Commercial Register Announcement ?) of Northwest Biotherapeutics GmbH.
Can Linda Powers give us an update of what is going on in Germany (the German subsidiary NW Bio GmbH)?
Is Fanny Schömann still the German representative and what is her relationship with Advent bioservices? (If any, but IMO there is evidence of that relationship)

Q4 (Less important, only question out of personal curiosity)

Late summer 2016 Linda Liau announced that 331 patients have been enrolled in the trial.
Why has Northwest Biotherapeutics waited three months to officially disclose this important information? (https://nwbio.com/nw-bio-provides-update-about-phase-3-trial-of-dcvax-l-for-newly-diagnosed-glioblastoma-multiforme-brain-cancer/)